Barrett’s Esophagus Test Identifies High-Risk Patients Missed by Standard Pathology
A study of 85 patients shows the TissueCypher test detected 15% with elevated cancer progression risk despite a non-dysplastic diagnosis.
A study of 85 patients shows the TissueCypher test detected 15% with elevated cancer progression risk despite a non-dysplastic diagnosis.
Color Health is providing free COVID testing through the CDC's Increasing Community Access to Testing program.
Ortho Clinical Diagnostics has a distribution agreement with Thermo Fisher Scientific to provide and support MAS Quality Controls and LabLink xL Quality Assurance Software through Ortho's Vitros QC Solutions to Vitros System customers worldwide.
The ethyl alcohol assay categorization enables moderate complexity laboratories to expand drug screening capabilities on the Abbott analyzer platform.
The infrared dye antibody conjugates aim to expand human phenotyping experiments innovation and make high-parameter flow cytometry more accessible.
The extraction-free library preparation technology is designed to deliver full transcriptome coverage for drug screening and toxicology studies.
Market growth driven by expanding clinical applications and regulatory innovation, with kits and reagents dominating product segments.
Multi-omics study reveals psychiatric comorbidities in bladder pain syndrome patients while demonstrating advantages in hematological malignancies and repeat expansion analysis.
The Seattle biotech company receives a $750,000 Gates Foundation grant to develop a rapid diagnostic using novel protein binders and a luciferase system.